Pulmonary Disease, Chronic Obstructive Clinical Trial
— PReSentOfficial title:
The Development and Feasibility Testing of a Pulmonary Rehabilitation Shared Decision Making Intervention for Patients With Chronic Obstructive Pulmonary Disease
Verified date | May 2023 |
Source | University Hospitals, Leicester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The PReSent study seeks to clarify the need, develop and test the feasibility and acceptability of a shared decision making intervention to support patients with Chronic Obstructive Pulmonary Disease make decisions about Pulmonary Rehabilitation. The study is split into two parts; (1) an observational study of healthcare professionals implicit attitudes, and (2) a feasibility and acceptability study assessing the value of the newly developed shared decision making intervention including a patient decision aid and decision coaching.
Status | Completed |
Enrollment | 144 |
Est. completion date | February 28, 2023 |
Est. primary completion date | February 23, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Phase 1: Measuring Healthcare Professionals attitudes towards patients with COPD Inclusion Criteria: - Willing and able to provide informed consent for participation in the research - A United Kingdom healthcare professional - A healthcare professional who has the capability to refer patients with COPD to Pulmonary Rehabilitation services - Male or female, aged 18+ years - Able to communicate in written and spoken English Exclusion Criteria: - Unable to provide valid informed consent - Healthcare professionals practising outside of the United Kingdom - A healthcare professional who does not refer patients with COPD to Pulmonary Rehabilitation services - Aged <18 years - Unable to understand written English as the Implicit Association Test is currently only available in English Phase 2: A Pulmonary Rehabilitation shared decision making intervention Patients:- Inclusion Criteria: - Willing and able to give informed consent for participation in the research - Male or female, aged 40+years - A confirmed diagnosis of COPD, post bronchodilator Forced Expiratory Volume 1/Full Vital Capacity ratio <70% - Eligible for attendance at a University Hospitals of Leicester Pulmonary Rehabilitation assessment - Able to communicate in written and spoken English Exclusion Criteria: - Unable to provide valid informed consent - Aged <40years - Primary diagnosis is another chronic respiratory condition. - Ineligible for attendance at a University Hospitals of Leicester PR assessment (e.g. significant comorbidity which limits exercise training - Unable to understand written English as the research information and shared decision making intervention is currently only available in English Healthcare professionals:- Inclusion Criteria: - A participant who is willing and able to give informed consent for participation in the research - A healthcare professional directly involved in the provision of the shared decision making intervention (e.g. a Pulmonary Rehabilitation specialist) - Male or female, aged 18+ years Exclusion criteria:- - A participant who is unable to provide valid informed consent - A healthcare professional not directly involved in the provision of the shared decision making intervention - Aged <18 years |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University Hospitals of Leicester NHS Trust | Leicester | Leicestershire |
Lead Sponsor | Collaborator |
---|---|
University Hospitals, Leicester |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Response latency | Presence of bias between stimuli | Baseline only | |
Primary | Feasibility of recruitment assessed by rate of recruitment to time and target | Recruitment to time (proposed study end date) and target (proposed sample size) | Through study completion, an average of 1 year | |
Primary | Feasibility of data collection/outcome measures assessed by rate of participant attrition | Data completeness | 1 year (end of study) | |
Primary | Intervention fidelity assessed by the Observer OPTION 5 Scale | This questionnaire is completed by the researcher when listening back to the shared decision making consultation audio recordings. It measures adherence to the principles of shared decision making. It is a 5 item questionnaire with a 4 point Likert Scale with scores ranging from 0-20. The higher the score the greater the adherence to the principles of shared decision making. | 1 year (end of study) | |
Secondary | Decisional conflict measured using the Decisional Conflict Scale | The Decisional Conflict Scale is a self-reported, 16 item questionnaire with a 5 point Likert Scale with scores ranging from 0-64. The lower the score indicates lower decisional conflict. | Baseline & immediately post intervention | |
Secondary | Patient activation as measured by the Patient Activation Measure | The Patient Activation Measure is a self-reported, 13 item questionnaire with a 5 point Likert Scale. Raw scores are transformed to a scaled score between of 0-100 with 100 indicating the highest activation in self-management. | Baseline & immediately post intervention | |
Secondary | Rate of attendance assessed by the proportion of participants who complete the intervention | Intervention completion is termed as the number of participants who attend the shared decision making consultation. | Baseline & immediately post intervention | |
Secondary | Patient attitudes/experiences of the study assessed through qualitative interviews with study participants | Patient attitudes/experiences of receiving the intervention | 1 year (end of study) | |
Secondary | Health professionals attitudes/experiences assessed through qualitative interviews with study participants | Health professional attitudes/experiences of delivering the intervention | 1 year (end of study) | |
Secondary | Uptake and adherence to Pulmonary Rehabilitation assessed by the proportion of participants who begin and complete Pulmonary Rehabilitation | Completion is termed as participants who complete at least 8 of the available 12 sessions (75%). | Baseline & immediately post intervention | |
Secondary | COPD Assessment Test | The COPD Assessment Test is a self-reported, 8 item questionnaire with a 6 point Likert Scale with scores ranging from 0-40. Higher scores indicate lower health-related quality of life. | Baseline & immediately post intervention | |
Secondary | Bristol COPD Knowledge Questionnaire | The Bristol COPD Knowledge questionnaire is a multiple choice, 65 item self-reported questionnaire. Scores range from 0-65 with higher scores indicating greater knowledge of COPD. | Baseline & immediately post intervention | |
Secondary | Chronic Respiratory Questionnaire | The Chronic Respiratory Questionnaire is a self-reported 20 item questionnaire using a 7 point Likert Scale. Scores range from 7-140 with higher scores indicating greater health-related quality of life. | Baseline & immediately post intervention | |
Secondary | Hospital Anxiety and Depression Scale | The Hospital Anxiety and Depression Scale is a multiple choice, 14 item questionnaire using a 4 point Likert scale. Scores range from 0-42 with higher scores indicating greater levels of anxiety and/or depression. | Baseline & immediately post intervention | |
Secondary | COPD Prem 9 | The COPD Prem 9 is a self-reported, 9 item questionnaire with a 6 point Likert scale. Scores range from 0-45 with lower scores indicating better health-related quality of life. | Baseline & immediately post intervention | |
Secondary | Medical Research Council Dyspnoea Scale | The Medical Research Council Dyspnoea Scale is a self-reported, 1 item questionnaire using a 5 point Likert Scale. Scores range from 1-5 with higher scores indicating greater perceived breathlessness. | Baseline & immediately post intervention | |
Secondary | Incremental Shuttle Walking Test | Maximal exercise capacity test | Baseline & immediately post intervention | |
Secondary | Endurance Shuttle Walking Test | Maximal exercise capacity test | Baseline & immediately post intervention | |
Secondary | Patient satisfaction with Pulmonary Rehabilitation assessed by internal hospital satisfaction questionnaire | This is a 6 item open ended questionnaire exploring patient satisfaction with Pulmonary Rehabilitation. The text is analysed using qualitative research methods. | Baseline & immediately post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|